Skip to main content

Table 1 Baseline clinical characteristics of enrolled patients

From: Effects of low-sodium bread on dietary compliance and fecal cultivable bacteria in a randomized controlled pilot trial in hypertensive subjects

 

Group

 

A (n = 19)

B (n = 17)

C (n = 18)

Age (y)

66.6 ± 6.3

63.2 ± 6.9

63.6 ± 6.2

BMI

28.4 ± 3.2

28.8 ± 5.1

27.8 ± 3.6

Systolic BP (mmHg)

138.4 ± 10.4

134.6 ± 9.8

139.3 ± 10.3

Diastolic BP (mmHg)

85.4 ± 6.8

84.1 ± 5.7

88.9 ± 5.7

FMD (%) *

7.4 ± 1.4

5.8 ± 2.0

5.6 ± 2.0

HbA1c (mmol/mol)

39.4 ± 6.1

38.5 ± 7.8

41.1 ± 10.6

Serum creatinine (mg/dl)

0.9 ± 0.2

0.9 ± 0.2

0.8 ± 0.2

MDRD (mL/min/1.73 m2)

77.3 ± 14.9

86.5 ± 21.6

87.1 ± 13.4

Urinary Sodium (mg/24 h)

3661 (2620,4071)

3408 (2695,4427)

3793 (3399,4982)

  1. *Performed on a subgroup of 26 patients
  2. Abbreviations: BMI Body Mass Index, BP Blood Pressure, FMD Flow-Mediated Dilation, HbA1c Glycated Hemoglobin, MDRD Modification of Diet in Renal Disease
  3. Age, BMI, systolic/diastolic BP, FMD, HbA1c, serum creatinine, MDRD are expressed as mean ± standard deviation, urinary sodium as median and interquartile range